PRELIMINARY PROGRAM
The program may be subject to change

Wednesday March 29, 9.00-12.00 - Pre-Course
Johan Zelano and Francesco Brigo

09.00-09.15 Welcome

09.15-10.00 Diagnosis of epilepsy in the context of other brain disease: application of the ILAE definition 

10.00-10.30 Coffee break 

10.30-11.15 Management of a seizures of different etiologies: stroke, TBI, CNS infections. What evidence is there? 

11.15-12.00 Epidemiology of different acquired epilepsies – an introduction. 

12.00 Lunch

Wednesday March 29, 13.00-17.00 - STESS conference

Session 1: Preclinical / epileptogenesis / disease modification

13.00-13.10 Opening remarks
Francesco Brigo and Johan Zelano

13.10-13.50  The immune system in epileptogenesis
Alberto Vogrig, Italy

13.50-14.30 Mechanisms of epileptogenesis in preclinical studies 
Emilio Russo, Italy

14.30-15.00 Coffee break

15.00-15.40 Modulating epileptogenesis: past and present human trials
Eugen Trinka, Austria 

15.40-16.20  Is there familial vulnerability for symptomatic epilepsies?
Jakob Christensen, Denmark

16.20-17.00  Platform session 
3x15 min presentations.

17.00-17.45 Sponsored symposium

17.45-19.00 Welcome reception

Thursday March 30 - STESS Conference

Session 2: Risk factors and biomarkers

09.00-09.40 The value of EEG as biomarker of epileptogenesis and seizures recurrence in different acquired epilepsies
Carla Bentes, Portugal

09.40-10.20 Reperfusion therapies and the risk of poststroke epilepsy 
Petra Redfors, Sweden

10.20-10.50 Coffee break

10.50-11.30  TBA: epileptogenesis
Christine Ekdahl, Sweden

11.30-12.00 Platform session 
2x15 min presentations

12.00-13.15  Lunch and sponsored lunch symposium

Session 3: Diagnosis, treatment and prognosis

13.15-13.55  Serum biomarkers for the diagnosis of structural acquired epilepsies
Laura Abraira, Spain

13.55-14.35  Tailored ASM selection in acquired epilepsy based on big data
Johan Zelano, Sweden

14.35-15.00 Coffee break

15.00-15.40 Predicting treatment resistance in acquired epilepsies
Simona Lattanzi, Italy

15.40-16.20 Prognosis of symptomatic epilepsies: the impact on survival
Rob Rouhl, The Netherlands

16.20-17.10 Platform session
3x15 min presentations

Friday March 31 - STESS Conference

Session 4: Prognosis continued, Hot topics 

09.00-09.40 Drug withdrawal in structural and symptomatic epilepsies
Morten Lossius, Norway

09.40-10.20 Epilepsy surgery for symptomatic epilepsies
Reetta Kälviäinen, Finland 

10.20-10.50 Coffee break

10.50-11.30  Seizures in and after brain infections
Ley Sander, UCL, UK. 

11.30-12.10 Tau and seizures – lessons from PET in dementia Michael Schöll, Sweden

12.00-13.00  Lunch

Last update: 2022-06-09